Trials / Completed
CompletedNCT00289406
Efficacy and Safety Study of S-Amlodipine Gentisate Compared to Amlodipine Besylate to Treat Mild-to-Moderate Hypertension
An 8 Weeks, Multi-Center, Randomized, Double Blinded, Comparative Phase 3 Clinical Trial to Assess the Efficacy and Safety of S-Amlodipine Gentisate Compared to Amlodipine Besylate in Patients With Mild-to-Moderate Hypertension
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 110 (planned)
- Sponsor
- SK Chemicals Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is to compare the antihypertensive effect and tolerability of S-amlodipine gentisate with those of amlodipine besylate in patients with mild to moderate hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | S-amlodipine gentisate | |
| DRUG | Amlodipine besylate |
Timeline
- Start date
- 2006-01-01
- Completion
- 2006-02-01
- First posted
- 2006-02-09
- Last updated
- 2007-03-06
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00289406. Inclusion in this directory is not an endorsement.